Literature DB >> 17635504

An agenda for research on adverse drug reactions.

J K Aronson.   

Abstract

Mesh：

Year:  2007        PMID： 17635504      PMCID： PMC2000628          DOI： 10.1111/j.1365-2125.2007.03014.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  16 in total

1.  Selling sickness: the pharmaceutical industry and disease mongering.

Authors:  Ray Moynihan; Iona Heath; David Henry
Journal:  BMJ       Date:  2002-04-13

Review 2.  Joining the DoTS: new approach to classifying adverse drug reactions.

Authors:  J K Aronson; R E Ferner
Journal:  BMJ       Date:  2003-11-22

3.  Better reporting of harms in randomized trials: an extension of the CONSORT statement.

Authors:  John P A Ioannidis; Stephen J W Evans; Peter C Gøtzsche; Robert T O'Neill; Douglas G Altman; Kenneth Schulz; David Moher
Journal:  Ann Intern Med       Date:  2004-11-16       Impact factor: 25.391

4.  Unity from diversity: the evidential use of anecdotal reports of adverse drug reactions and interactions.

Authors:  Jeffrey K Aronson
Journal:  J Eval Clin Pract       Date:  2005-04       Impact factor: 2.431

Review 5.  Clarification of terminology in drug safety.

Authors:  Jeffrey K Aronson; Robin E Ferner
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 6.  The role of data mining in pharmacovigilance.

Authors:  Manfred Hauben; David Madigan; Charles M Gerrits; Louisa Walsh; Eugene P Van Puijenbroek
Journal:  Expert Opin Drug Saf       Date:  2005-09       Impact factor: 4.250

7.  Communicating information about drug safety.

Authors:  R E Ferner; J K Aronson
Journal:  BMJ       Date:  2006-07-15

8.  A prescription for better prescribing.

Authors:  J K Aronson
Journal:  Br J Clin Pharmacol       Date:  2006-05       Impact factor: 4.335

9.  Perception of risk of adverse drug reactions by medical students: influence of a 1 year pharmacological course.

Authors:  G Durrieu; C Hurault; V Bongard; C Damase-Michel; J L Montastruc
Journal:  Br J Clin Pharmacol       Date:  2007-03-22       Impact factor: 4.335

10.  Identifying systematic reviews of the adverse effects of health care interventions.

Authors:  Su Golder; Heather M McIntosh; Yoon Loke
Journal:  BMC Med Res Methodol       Date:  2006-05-08       Impact factor: 4.615
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.